Prediction and analysis of albumin-bilirubin score combined with liver function index and carcinoembryonic antigen on liver metastasis of colorectal cancer

doi:10.4240/wjgs.v16.i6.1670

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1588)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-5) series.

Item

Count

PDF

HTML

946

Figures (1-6)

195

Tables (1-5)

178

Sum=1356

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

156

Sum=187

Jun 27, 2024 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Surg. Jun 27, 2024; 16(6): 1670-1680
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1670

Table 1 Baseline data between liver metastasis group and non-liver metastasis group (n = 195)

Index	Liver metastases group (n = 70)	Non-liver metastases group (n = 125)	P value
Age (mean ± SD, yr)	58.3 ± 12.5	61.7 ± 12.0	0.067
Gender, n (%)			0.865
Man	40 (57.1)	73 (58.4)
Female	30 (42.9)	52 (41.6)
Primary tumor location, n (%)			0.042
Colon	38 (54.3)	49 (39.2)
Rectum	32 (45.7)	76 (60.8)
BMI, M (P₂₅, P₇₅), kg/m²	22.5 (21.4, 24.7)	22.1 (20.2, 25.0)	0.28
TBIL, M (P₂₅, P₇₅), μmol/L	14.9 (11.6, 24.7)	12.8 (9.4, 16.9)	0.001
DBIL, M (P₂₅, P₇₅), μmol/L	7.2 (4.3, 10.6)	3.3 (2.3, 5.4)	< 0.001
IBIL, M (P₂₅, P₇₅), μmol/L	9.3 (5.2, 14.3)	8.8 (6.0, 12.1)	0.642
ALT, M (P₂₅, P₇₅), U/L	31.5 (16.0, 54.8)	17.0 (10.0, 25.0)	< 0.001
AST, M (P₂₅, P₇₅), U/L	40.0 (27.8, 87.3)	20.0 (16.0, 25.5)	< 0.001
AST/ALT, M (P₂₅, P₇₅)	1.6 (1.1, 2.2)	1.4 (0.9, 1.7)	0.005
TP, M (P₂₅, P₇₅), g/L	65.1 (58.9, 70.6)	69.4 (64.3, 73.4)	0.001
ALB, M (P₂₅, P₇₅), g/L	36.3 (29.5, 40.2)	41.4 (38.3, 44.1)	< 0.001
GLO, M (P₂₅, P₇₅), g/L	29.3 (24.7, 33.5)	28.3 (24.0, 31.0)	0.124
A/G (mean ± SD)	1.2 ± 0.4	1.5 ± 0.3	< 0.001
GGT, M (P₂₅, P₇₅), U/L	59.0 (25.8, 148.0)	18.0 (13.0, 25.5)	< 0.001
ALP, M (P₂₅, P₇₅), U/L	122.5 (77.5, 211.0)	76.0 (63.0, 90.5)	< 0.001
AFP, M (P₂₅, P₇₅), μg/L	2.6 (1.6, 3.4)	2.5 (1.8, 3.2)	0.845
CEA, M (P₂₅, P₇₅), μg/L	79.5 (12.5, 476.0)	2.9 (1.8, 5.9)	< 0.001
CA125, M (P₂₅, P₇₅), U/mL	21.3 (11.0, 54.7)	11.1 (7.9, 16.7)	< 0.001
CA19-9, M (P₂₅, P₇₅), U/mL	85.5 (17.3, 801.7)	10.9 (7.5, 17.0)	< 0.001
ALBI score, M (P₂₅, P₇₅)	-2.3 (-2.7, -1.6)	-2.8 (-3.0, -2.6)	< 0.001

BMI: Body mass index; TBIL: Total bilirubin; DBIL: Direct bilirubin; IBIL: Indirect bilirubin; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; TP: Total protein; ALB: Albumin; GLO: Globulin; A/G: Albumin/globulin; GGT: Gamma-glutamyltransferase; ALP: Alkaline phosphatase; AFP: Alpha-fetoprotein; CEA: Carcinoembryonic antigen; CA125: Carbohydrate antigen 125; ALBI: Albumin bilirubin.

Citation: Wang ZM, Pan SP, Zhang JJ, Zhou J. Prediction and analysis of albumin-bilirubin score combined with liver function index and carcinoembryonic antigen on liver metastasis of colorectal cancer. World J Gastrointest Surg 2024; 16(6): 1670-1680
URL: https://www.wjgnet.com/1948-9366/full/v16/i6/1670.htm
DOI: https://dx.doi.org/10.4240/wjgs.v16.i6.1670